US NIH starts early-stage trials of flu vaccines on humans

Robert Besser
20 Sep 2023, 11:07 GMT+10

This week, the US National Institutes of Health said that it started early-stage human trials on FluMos-v2, its experimental vaccine targeting six strains of the influenza virus
The institute said it developed FluMos-v2 to offer protection against four strains of the influenza A virus and two strains of the influenza B virus
The institute announced that the study will enroll 24 healthy volunteers aged between 18 and 50, who will receive two intramuscular injections of FluMos-v2 at a gap of 16 weeks

BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, its experimental vaccine targeting six strains of the influenza virus.

The institute said it developed FluMos-v2 to offer protection against four strains of the influenza A virus and two strains of the influenza B virus.

"An ideal universal influenza vaccine could be taken less frequently than once a year and protect against multiple strains of influenza virus. With each new universal influenza vaccine candidate and clinical trial, we take another step closer to that goal," said Hugh Auchincloss, acting director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.

The institute announced that the study will enroll 24 healthy volunteers aged between 18 and 50, who will receive two intramuscular injections of FluMos-v2 at a gap of 16 weeks.

FluMos-v2 has been designed by researchers at NIAID's Vaccine Research Center.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Venezuela Star.

More Information

27 ℃

Partly Cloudy in Caracas

Business

Section

U.S. stocks close higher after volatile day, dollar dives

NEW YORK, New York - U.S. stocks closed in positive territory despite a volatile day Tuesday. Spending much time in ...

Salmonella cases force recall of more cantaloupe brands by FDA

WASHINGTON D.C.: On November 24, the U.S. Food and Drug Administration (FDA) recalled three more brands of whole and pre-cut ...

EV sales in US up 9%, still below many countries

DETROIT, Michigan: US electric vehicle (EV) sales are expected to reach a record of 9% of all passenger vehicles this ...

U.S. stocks weaken as traders return after Thanksgiving

NEW YORK, New York - U.S. stocks closed marginally lower as traders returned to their desks Monday following the Thanksgiving ...

Warren Buffett gives away Berkshire stocks worth $866 million

OMAHA, Nebraska: On November 21, Warren Buffett announced a donation of Berkshire Hathaway stocks worth some US$866 million to four ...

Hawaii looks to streamline travel process for Japanese visitors

HONOLULU, Hawaii: The islands' leaders are working on streamlining the travel process for Japanese tourists, making it more convenient for ...

International

Section